About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in New York | 64 Studies

Clinical Trials SchizophreniaNew York

Schizophrenia Clinical Trials in New York

Find 64 clinical trials for schizophrenia near New York, New York. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 64 trials

CompletedTDCS for Auditory Hallucinations in SchizophreniaThe purpose of the present research is to test a potential new treatment for auditory verbal hallucinations in schizophrenia that uses transcranial Direct Current Stimulation…NCT01898299·New York, New York and 1 other RecruitingExercise and Olanzapine-samidorphanThis is a single site trial in 30 patients with schizophrenia, schizoaffective, or bipolar I/II/NOS disorder in which all participants will receive eight weeks of olanzapine and…NCT06740890·New York, New York RecruitingClozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical TrialTwo-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site…NCT05208190·Los Angeles, California and 6 others

Schizophrenia Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric DisordersThe investigators propose to recruit individuals with schizophrenia who are symptomatically stable and already taking medications to participate in this study.NCT01519557·New York, New York

CompletedTrial of Treatment for Internalized Stigma in SchizophreniaThe purpose of the present study is to build upon the investigators' previous exploratory intervention development study by conducting an adequately-powered, randomized controlled…NCT02421237·New York, New York

CompletedOnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) GrantOur team will develop a prototype game (OnTrack\>The Game) in which users play the role of a person who has experienced First Episode Psychosis and move through animated…NCT02415764·Needham, Massachusetts and 1 other

CompletedBiomarkers of Conversion Risk and Treatment Response in Early-Stage SchizophreniaSchizophrenia (SZ) is a highly debilitating neuropsychiatric disorder of young adulthood onset and a leading cause of disability worldwide.NCT03323437·New York, New York

CompletedDECIFER: Depression and Citalopram In First Episode RecoveryThis study seeks to examine the effectiveness of citalopram added to treatment with any oral or injectable second-generation antipsychotic plus standardized psychoeducation in…NCT01041274·New York, New York

RecruitingA PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaThis is a single site clinical trial in which 12 participants with schizophrenia will be randomized to one of three doses of treatment with Cobenfy for 5 weeks.NCT07423546·New York, New York

Not yet recruitingDecNef for AVH in SchizophreniaThe purpose of this study is to learn whether a research neurofeedback training approach done during MRI scans may help reduce hallucinations such as the experience of hearing…NCT07779226·New York, New York and 1 other

CompletedMusic to Reduce Use of Smoking in Patients With SchizophreniaThe purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating…NCT03190161·New York, New York

CompletedPEARL Schizophrenia MaintenanceLurasidone HCI is a compound that is FDA-approved for the treatment of schizophrenia.NCT01435928·Springdale, Arizona and 74 others

CompletedD-Cycloserine Augmentation of Cognitive Behavioral Therapy for DelusionsThis study is a placebo-controlled 12 week trial of DCS augmentation of once-weekly CBT sessions in 60 schizophrenia subjects with antipsychotic-resistant delusions.NCT01981759·Baltimore, Maryland and 1 other

CompletedCSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar IllnessThe purpose of this study is to detect genetic associations for the development of schizophrenia (SZ) and bipolar illness (BP) by comparing Veterans with these diseases to…NCT01149551·Birmingham, Alabama and 24 others

CompletedValproate in Dementia (VALID)The purpose of this trial is to demonstrate whether valproate therapy delays the emergence of agitation and/or psychosis in outpatients with probable Alzheimer's disease (AD) who…NCT00071721·Sun City, Arizona and 45 others

Active not recruitingGlutamatergic Mechanisms of Psychosis and Target Engagement (SA1)50 healthy volunteers (HV) will participate in 2 identical ketamine-induced pharmacoBOLD (phBOLD) sessions at least 7 days apart.NCT04589208·New York, New York

TerminatedAn Extension Protocol for Patients Who Previously Completed the TMS Pilot StudyThis is an open-label extension study to continue to evaluate the safety, tolerability and efficacy of the Repetitive Transcranial Magnetic Stimulation (rTMS) in subjects with…NCT05526833·New York, New York

CompletedClinical Trial of AVL-3288 in Schizophrenia PatientsSingle-center, outpatient, randomized, double-blind, placebo-controlled, 3-treatment-phase, cross-over study to evaluate the safety, tolerability and efficacy of two oral doses of…NCT02978599·New York, New York

CompletedTocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of SchizophreniaRandomized, double-blind clinical trial of tocilizumab vs. placebo as add-on treatment for residual positive, negative, and cognitive symptoms in schizophrenia.NCT02034474·New York, New York

CompletedThe Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.The aim of this study is to look at the effects of Aerobic Exercise (AE) on daily and neurocognitive functioning including memory, attention, the ability to plan activities, and…NCT01897064·New York, New York

Page 1 of 4Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia